Immune Response to Cat: Regulatory and Effector T Cells
Immune Response to Cat: Regulatory and Effector T Cells
批准号:
8451525
负责人:
Judith A Woodfolk
金额:
$34.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2015-04-30
关键词:
AftercareAllergensAllergicAllergic DiseaseAllergic inflammationArchitectureAtopic DermatitisAutologous Dendritic CellsBiological AssayBiopsyBiopsy SpecimenCellsChronicColorConflict (Psychology)DataDevelopmentDiseaseElementsExhibitsExposure toFailureFelis catusFlow CytometryGene ExpressionGlucocorticoidsGoalsHarvestHealthHumanIL2RA geneIL7R geneImageImmuneImmune responseImmunofluorescence ImmunologicImmunotherapyIn VitroInflammationInflammatoryInflammatory ResponseInterleukin-10Interleukin-4InvestigationKnowledgeLasersLifeMediatingMicroscopyMitosisMolecularMonitorPatch TestsPathway interactionsPatientsPeptidesPhenotypePhysiologic pulsePlayPredispositionPropertyReceptor SignalingRegulatory T-LymphocyteReportingRoleSTAT5A geneSTAT6 geneScanningSignaling MoleculeSiteSkinSmall Interfering RNAStaining methodStainsSuperantigensSurfaceSystemT cell activating factorT cell responseT-Cell DevelopmentT-LymphocyteTechnologyTestingVariantWorkatopybasecell typecytokinefunctional restorationhuman TSLP proteinimprovedin vivokeratinocytenovelreconstitutionresponseskin disorderskin lesiontranscription factortreatment strategy
中文摘要
描述(由申请人提供):了解T细胞在慢性变态反应性炎症性皮肤病--特应性皮炎(AD)中所起的作用,对于开发这种使人衰弱的疾病的特定治疗方法具有很高的相关性。调节性T细胞(Tregs)通常会抑制健康受试者的促炎T细胞。这项拟议的研究将调查AD患者的Tregs是否真的能促进皮肤的炎症反应。主要目的如下:(1)检测Tregs在暴露于变态反应性炎症部位表达的因子后转化为分泌Th2细胞因子的致病T细胞的能力;(2)确定减少Th2途径的治疗是否能在体外增强保护性Tregs的诱导。低表达的CD127(IL-7R 1链)将被用于从AD患者中分离自然(CD25+CD127lo)和适应性(CD25-CD127lo)Tregs。数据表明,这些患者的自然Tregs可以获得Th2效应特性,而产生IL-10的适应性Tregs具有保护性。在目标1中,研究将阐明不同的CD127lo Treg类型的特性,比较它们对AD皮肤中表达的T细胞激活因子的敏感性,并确定它们的致病和保护潜力。多色流式细胞术和标准的体外T细胞分析将用于分析不同CD127lo Treg类型的表型和抑制功能。CD127lo T细胞对AD皮肤中表达的Th2促进因子(胸腺间质淋巴生成素(TSLP)、变应原或细菌超抗原)的反应性将使用流式细胞仪成像技术在单细胞水平上鉴定正在进行有丝分裂的IL-4+T细胞。参与Th2极化和IL-4受体信号转导的转录因子(STAT5和STAT6)在TSLP介导的Treg激活和变应原放大这一反应中的作用将得到评估。小干扰RNA将被用来测试抑制CD25+CD127lo树突状细胞中的Th2信号分子是否可以阻断效应器功能并恢复抑制器活性。在目标2中,过敏性炎症部位存在不同类型的CD127lo Tregs将首先在特应性斑贴试验(APT)部位的皮肤活检中得到确认。通过分析CD25+CD127lo Tregs与APT部位的角质形成细胞培养的Th2效应特性,将在一种新的皮肤外植体试验中测试Tregs在这些部位转化为Th2效应器的能力。在目标3中,目标是确定可用于增强保护性Treg诱导的治疗策略。将使用一种诱导表达IL-10的T细胞的变应原变体(H22-FEL d1)来分析分泌IL-10的Treg与其他CD127lo Treg类型的关系。过敏原特异性的IL-10分泌树突状细胞将在体外扩增,以确定它们的保护特性,并比较来自不同CD127lo前体的IL-10分泌树突状细胞。Th2细胞因子在体外抑制产生IL-10的Tregs的作用将被检测。这种Treg类型诱导的变化将在体外监测治疗期间的变化,这些治疗已知可以改善皮肤状况,减少Th2途径。
英文摘要
DESCRIPTION (provided by applicant): Understanding the role that T cells play in the chronic allergic inflammatory skin disorder, atopic dermatitis (AD), is highly relevant to the development of specific treatments for this debilitating disease. Regulatory T cells (Tregs) normally suppress pro-inflammatory T cells in healthy subjects. The proposed studies will investigate whether Tregs from AD patients can actually contribute to inflammatory responses in the skin. The primary objectives are as follows: (1) To examine the capacity for Tregs to convert to pathogenic T cells which secrete Th2 cytokines upon exposure to factors expressed at the site of allergic inflammation; (2) To determine whether treatments which diminish Th2 pathways can enhance the induction of protective Tregs in vitro. Low expression of CD127 (IL-7R 1 chain) will be used to isolate natural (CD25+CD127lo) and adaptive (CD25negCD127lo) Tregs from AD patients. Data suggests that natural Tregs from these patients can acquire Th2 effector properties, while IL-10-producing adaptive Tregs are protective. In Aim 1, studies will elucidate the properties of distinct CD127lo Treg types, compare their susceptibility to T cell-activating factors expressed in AD skin, and determine their pathogenic versus protective potential. Multi-color flow cytometry and standard in vitro T cell assays will be used to analyze the phenotype and suppressive function of distinct CD127lo Treg types. Responsiveness of CD127lo T cells to Th2-promoting factors expressed in AD skin (thymic stromal lymphopoietin (TSLP), allergen, or bacterial superantigen) will be examined using flow cytometry imaging to identify IL-4+ T cells undergoing mitosis at the single-cell level. The role of transcription factors involved in Th2 polarization and IL-4 receptor signaling (STAT5 and STAT6) will be assessed in Treg activation mediated by TSLP and in amplification of this response by allergen. Small interfering RNAs will be used to test whether inhibiting Th2 signaling molecules in CD25+CD127lo Tregs can block effector function and restore suppressor activity. In Aim 2, the presence of distinct types of CD127lo Tregs at the site of allergic inflammation will first be confirmed in skin biopsies from atopy patch test (APT) sites. The capacity for Tregs to convert to Th2 effectors at these sites will be tested in a novel skin explant assay by analyzing the Th2 effector properties of CD25+CD127lo Tregs cultured with keratinocytes from APT sites. In Aim 3, the goal is to identify treatment strategies which could be used to enhance induction of protective Tregs. The relationship of IL-10-secreting Tregs to other CD127lo Treg types will be analyzed using an allergen variant (H22-Fel d 1) which induces IL-10-expressing T cells. Allergen-specific IL-10-secreting Tregs will be expanded in vitro in order to determine their protective properties and to compare IL-10-secreting Tregs derived from distinct CD127lo precursors. The role of Th2 cytokines in inhibiting induction of IL-10-producing Tregs in vitro will be examined. Changes in induction of this Treg type will be monitored ex vivo during treatments which are known to improve skin condition and to diminish Th2 pathways.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Reply: To PMID 24084078.
回复:PMID 24084078。
DOI:
10.1016/j.jaci.2014.06.009
发表时间:
2014
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Romeo,MartinJ, Agrawal,Rachana, Pomés,Anna, Woodfolk,JudithA]
通讯作者:
Woodfolk,JudithA
DOI:
10.1111/cea.12016
发表时间:
2013-02
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
影响因子:
--
作者:
[Wisniewski J, Agrawal R, Woodfolk JA]
通讯作者:
Woodfolk JA
DOI:
10.1159/000323305
发表时间:
2011
期刊:
Current problems in dermatology
影响因子:
--
作者:
[Agrawal R, Wisniewski JA, Woodfolk JA]
通讯作者:
Woodfolk JA
Flow cytometry imaging identifies rare T(H)2 cells expressing thymic stromal lymphopoietin receptor in a "proallergic" milieu.
流式细胞术成像可识别“促过敏”环境中表达胸腺基质淋巴细胞生成素受体的稀有 T(H)2 细胞。
DOI:
10.1016/j.jaci.2010.07.023
发表时间:
2010
期刊:
The Journal of allergy and clinical immunology
影响因子:
--
作者:
[Reefer,AmandaJ, Hulse,KathrynE, Lannigan,JosephineA, Solga,MichaelD, Wright,PaulW, Kelly,LibbyA, Patrie,James, Chapman,MartinD, Woodfolk,JudithA]
通讯作者:
Woodfolk,JudithA
DOI:
10.1016/j.jaci.2013.08.006
发表时间:
2014-04
期刊:
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
影响因子:
14.2
作者:
[Romeo, Martin J., Agrawal, Rachana, Pomes, Anna, Woodfolk, Judith A.]
通讯作者:
Woodfolk, Judith A.
Immune Programs and Related T Cell Mechanisms of Pulmonary Complications After COVID-19 Illness
-
批准号:10886167
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2023
-
负责人:Judith A Woodfolk
-
依托单位:
Protective and Pathogenic T Cells Responding to SARS-CoV-2 in Health and Disease
-
批准号:10218954
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2021
-
负责人:Judith A Woodfolk
-
依托单位:
Protective and Pathogenic T Cells Responding to SARS-CoV-2 in Health and Disease
-
批准号:10488185
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2021
-
负责人:Judith A Woodfolk
-
依托单位:
Regulation of TSLP receptor expression and function in eczema in mice and man
-
批准号:8651423
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2011
-
负责人:Judith A Woodfolk
-
依托单位:
Regulation of TSLP receptor expression and function in eczema in mice and man
-
批准号:8106840
-
项目类别:
-
资助金额:$58.16万
-
财政年份:2011
-
负责人:Judith A Woodfolk
-
依托单位:
Regulation of TSLP receptor expression and function in eczema in mice and man
-
批准号:8460063
-
项目类别:
-
资助金额:$51.59万
-
财政年份:2011
-
负责人:Judith A Woodfolk
-
依托单位:
Regulation of TSLP receptor expression and function in eczema in mice and man
-
批准号:8244445
-
项目类别:
-
资助金额:$54.31万
-
财政年份:2011
-
负责人:Judith A Woodfolk
-
依托单位:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
-
批准号:8167150
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2010
-
负责人:Judith A Woodfolk
-
依托单位:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
-
批准号:7951462
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2009
-
负责人:Judith A Woodfolk
-
依托单位:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
-
批准号:7718542
-
项目类别:
-
资助金额:$3.36万
-
财政年份:2008
-
负责人:Judith A Woodfolk
-
依托单位:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
-
批准号:7606686
-
项目类别:
-
资助金额:$10.42万
-
财政年份:2007
-
负责人:Judith A Woodfolk
-
依托单位:
CD25+CD4+ T cells and IgE-mediated disease in humans
-
批准号:7151381
-
项目类别:
-
资助金额:$24.07万
-
财政年份:2006
-
负责人:Judith A Woodfolk
-
依托单位:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
-
批准号:7205509
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2005
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Respone to Cat: Regulatory and Effector T Cells
-
批准号:6890460
-
项目类别:
-
资助金额:$26.67万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Respone to Cat: Regulatory and Effector T Cells
-
批准号:7064830
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Response to Cat: Regulatory and Effector T Cells
-
批准号:7822925
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Response to Cat: Regulatory and Effector T Cells
-
批准号:8061593
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Response to Cat: Regulatory and Effector T Cells
-
批准号:7581789
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Respone to Cat: Regulatory and Effector T Cells
-
批准号:7227798
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
Immune Response to Cat: Regulatory and Effector T Cells
-
批准号:8259508
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2004
-
负责人:Judith A Woodfolk
-
依托单位:
海外基金